Sign In | Join Free | My frbiz.com
frbiz.com
Products
Search by Category
Home > Other Chemical Reagents >

Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits

Categories Infectious Disease Rapid Test Kits
Brand Name: Aichek
Model Number: FLU-A01
Certification: CE
Place of Origin: China
MOQ: 5000 Test
Price: negotiable
Payment Terms: T/T
Supply Ability: negotiable
Packaging Details: 40box/carton
Storage: 2℃-30℃
Sample Type: Swab
User: Professional
Accuracy: 99.6% (97.7%-99.9%)
Certificate: CE ISO 13485
OEM: OEM customized packing avaliable
Formats: 25T/box 1T/box
After-sales Service: Available
Key words: COVID-19 and Influenza A+B Antigen Rapid Test
For the crowd: Preliminary screening of infected people
  • Haven't found right suppliers
  • Our buyer assistants can help you find the most suitable, 100% reliable suppliers from China.
  • And this service is free of charge.
  • we have buyer assistants who speak English, French, Spanish......and we are ready to help you anytime!
Submit Buying Request
  • Product Details
  • Company Profile

Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits

Double check COVID-19 and Influenza A+B Antigen Rapid Test with CE

Product NameDouble check COVID-19 and Influenza A+B Antigen Rapid Test with CE
FormatsStrip(3mm)Device(4mm)
Place of OrigenChina
Specimenswab
Read Time15 minutes
Shelf life2 years
Package25 device/box or 50 strip/Box
Storage2℃-30℃


For professional in vitro diagnostic use only

【INTENDED USE】

The Influenza A+B Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of influenza A and B antigens in nasal swab or throat swab or nasal aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.

The COVID-19 Antigen Rapid Test device is a lateral flow chromatographic immunoassay for the qualitative detection of the nucleocapsid(N) protein antigen from SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab. It provides an aid in the diagnosis of infection with 2019-nCOV.

Sensitivity, Specificity and Accuracy

The Influenza A+B Rapid Test Device (Swab/Nasal Aspirate) has been evaluated with specimens obtained from the patients. RT-PCR is used as the reference method for the Influenza A+B Rapid Test Device (Swab/Nasal Aspirate). Specimens were considered positive if RT-PCR indicated a positive result. Specimens were considered negative if RT-PCR indicated a negative result Nasal Swab Specimen.

Accuracy
A side-by-side comparison was conducted by the results of the test reagent and RT-PCR. 420 clinical swab specimens (including
Ct≤33 and Ct>33)were evaluated, 111 were positive and 309 were negative. Base on the results from the clinical studies, the
statistical analysis was made as follows:
Clinical sensitivity:98.10% (95% CI: 93.32%~99.48%)
Clinical specificity:99.68% (95% CI: 98.19%~99.94%)
Total Coincidence rate:99.28% (95% CI: 97.89%~99.75%).
Clinical sensitivity:97.30% (95% CI: 92.35%~99.08%)
Clinical specificity:99.68% (95% CI: 98.19%~99.94%)
Total Coincidence rate:99.05% (95% CI: 97.58%~99.63%).
Quality Swab 97.7% Influenza AB Test Infectious Disease Rapid Test Kits for sale
Send your message to this supplier
 
*From:
*To: Hangzhou Aichek Medical Technology Co.,Ltd
*Subject:
*Message:
Characters Remaining: (0/3000)
 
Inquiry Cart 0